PubRank

Deepa Naishadham

Author PubWeight™ 198.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer statistics, 2012. CA Cancer J Clin 2012 87.38
2 Cancer statistics, 2013. CA Cancer J Clin 2013 84.72
3 Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med 2005 6.14
4 Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 2012 3.58
5 Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013 2.44
6 Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology 2006 2.06
7 Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008 2.02
8 The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med 2012 1.92
9 Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 2010 1.78
10 Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology 2006 1.73
11 DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trial. J Hepatol 2008 1.71
12 Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology 2010 1.52
13 Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 2009 1.46
14 Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer 2012 1.14
15 Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol 2012 1.05
16 Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology 2009 1.03
17 Social disparities in the burden of occupational exposures: results of a cross-sectional study. Am J Ind Med 2007 1.02
18 Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol 2008 0.96
19 Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology 2011 0.95
20 Work-to-family spillover and fruit and vegetable consumption among construction laborers. Am J Health Promot 2007 0.95
21 Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality. Cancer 2012 0.82
22 Issues in design and implementation in an urban birth cohort study: the Syracuse AUDIT project. J Urban Health 2006 0.79
23 Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C. Am J Gastroenterol 2012 0.78
24 Genetic variations in heme oxygenase-1 and chronic hepatitis. Hepatology 2010 0.76
25 Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C. Am J Gastroenterol 2010 0.76